Recalls & Warnings May 08, 2024 APG SEVEN Warned for Promoting Products for Cancer, Depression, Arthritis, & More On April 18, 2024, the FDA issued a Warning Letter to APG SEVEN, INC following a review of the companys product labels, website, and social media, which found statements about the companys BioMoringa, BioDiabetin, Maca Plus, BioProstate, Immune Support, HongoTrap, Honbacterol,
Peptide Therapy What Is BPC-157
Hard Tissue Biol
Additionally, NNMT inhibition appears to increase expression of GLUT4 transporters, which move glucose from the bloodstream into cells
State Topical formulation Storage Per product label Notes Compounded topicals follow the compounder's beyond-use date